Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Multiple Pathogens Detected Using Luminescent Nanocrystal Tags

By LabMedica International staff writers
Posted on 14 May 2014
Luminescent nanocrystals and a high-speed scanner enable rapid detection of multiple pathogens in a single test.

A research team using tunable luminescent nanocrystals as tags to advance medical and security imaging have successfully applied them to high-speed scanning technology and detected multiple viruses within minutes. More...
The team previously developed a way to control the length of time light from a luminescent nanocrystal lingers, which introduced the dimension of time in addition to color and brightness in optical detection technology. Detection based on the lifetime of the light from a nanocrystal as well as its specific color, exponentially increases the possible combinations and unique tags that could be created for biomedical screens.

The research, led by Macquarie University (Sydney, Australia) and Purdue University West Lafayette, IN, USA) follows the team's earlier success in developing a way to control the length of time light from a luminescent nanocrystal lingers, which introduced the dimension of time in addition to color and brightness in optical detection technology.

Detection based on the lifetime of the light from a nanocrystal as well as its specific color exponentially increases the possible combinations and unique tags that could be created for biomedical screens.

Yiqing Lu, a researcher at Macquarie University, who led the research explained, "We now are able to build a huge library of lifetime color-coded microspheres to perform multiple medical tasks or diagnoses at the same time. The time saved by omitting the need to grow or amplify a culture sample for testing and eliminating the need to run multiple tests will save future patients precious time so treatment can begin, which can be life-saving when managing aggressive diseases."

The technology could enable screens that identify thousands of different target molecules simultaneously, said J. Paul Robinson, the professor of Cytomics in Purdue's College of Veterinary Medicine and professor in Purdue's Weldon School of Biomedical Engineering, who was involved in the research.

"This is the second part of the puzzle," said Prof. Robinson, who led the biological testing of the technology. "Now [we have] successfully measured the lifetimes of these tags on the fly at thousands of samples per second. The next step is to perform such high-throughput testing within a liquid, like water, blood or urine. That will open the door to widespread biological use and clinical applications, as well as the detection of pathogens in food or water."

Robinson's research focuses on flow cytometry, the analysis of cells that are contained in a liquid flowing past a laser beam. In addition to developing instrumentation to measure the tags, he plans to explore the technology's health care and biodetection applications.

The research team attached unique tags to DNA strands of HIV, Ebolavirus, Hepatitis B virus, and Human Papillomavirus 16. The tags were accurately read and distinguished at high speeds in suspension arrays. The team's work is described online in Nature Communications.

Related Links:

Macquarie University
Purdue University West Lafayette



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.